Understanding the Scope and Claims of United States Patent 10,238,709
Introduction
United States Patent 10,238,709, titled "Method of treating diseases," is a significant patent that outlines a novel approach to treating various diseases, including acromegaly and other conditions. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape it operates within.
Patent Overview
The patent, filed under the application number US15/014,634, was granted on March 19, 2019. It is assigned to inventors who have developed a method for treating diseases using specific dosage forms and administration methods.
Scope of the Patent
The scope of the patent is defined by its claims, which are the legally binding descriptions of the invention. Here are some key aspects of the patent's scope:
Diseases Treated
The patent covers methods for treating acromegaly, a condition resulting from excessive growth hormone production, as well as other diseases and conditions such as idiopathic intracranial hypertension and cluster headache syndrome[1].
Dosage Forms
The invention involves the use of specific dosage forms, including capsules and suspensions, which are designed to deliver the active ingredients effectively. The patent details the composition and preparation of these dosage forms[1].
Administration
The method of administration is a critical component of the patent. It specifies how the dosage forms should be administered to achieve the desired therapeutic effects. This includes details on dosage, frequency, and route of administration[1].
Claims Analysis
The claims of the patent are the heart of its legal protection. Here are some key points about the claims:
Independent Claims
The patent includes multiple independent claims that define the core aspects of the invention. These claims are broad enough to cover the essential features of the method but narrow enough to be specific and enforceable[1].
Dependent Claims
Dependent claims further refine the independent claims by adding additional limitations or details. These claims help to narrow the scope and provide additional protection against infringement[1].
Claim Length and Count
Research on patent scope suggests that the length and count of claims can influence the patent's breadth and validity. Narrower claims with fewer dependencies tend to have a higher probability of grant and shorter examination processes[3].
Prior Art and Novelty
The patent must demonstrate novelty and non-obviousness over prior art. The inventors have identified prior art keywords such as octreotide, IGF (Insulin-Like Growth Factor), and specific dosage forms, indicating that their method offers a unique approach compared to existing treatments[1].
Patent Landscape
The patent landscape surrounding US 10,238,709 involves several key factors:
Litigation and Settlements
Patent litigation and settlements are common in the pharmaceutical industry. Similar patents often face legal challenges, as seen in cases like Novo Nordisk Inc. v. Rio Biopharmaceuticals, Inc., where settlements and Paragraph IV certifications play a crucial role[2].
Patent Valuation
The value of a patent like US 10,238,709 can be substantial. The income approach, which considers future benefits, and the market approach, which looks at what a willing buyer would pay, are common methods for valuing patents. For example, large patent portfolios have been sold for hundreds of millions of dollars, highlighting the significant value of intellectual property in this field[4].
Patent Scope Metrics
Metrics such as independent claim length and count can provide insights into the patent's scope and quality. Narrower claims tend to be more enforceable and less likely to face validity challenges during litigation[3].
Impact on the Pharmaceutical Industry
This patent has several implications for the pharmaceutical industry:
Innovation Incentives
The granting of this patent can incentivize further innovation in the treatment of acromegaly and other related diseases. By providing exclusive rights to the inventors, it encourages investment in research and development[3].
Competitive Landscape
The patent affects the competitive landscape by preventing other companies from using the same method without permission. This can lead to settlements and licensing agreements, as seen in various ANDA (Abbreviated New Drug Application) litigation cases[2].
Key Takeaways
- Disease Treatment: The patent covers methods for treating acromegaly and other conditions using specific dosage forms and administration methods.
- Claims Analysis: The patent includes independent and dependent claims that define the scope of the invention.
- Prior Art: The method must be novel and non-obvious over prior art, which includes existing treatments and dosage forms.
- Patent Landscape: The patent operates within a complex landscape of litigation, settlements, and valuation considerations.
- Industry Impact: The patent incentivizes innovation and affects the competitive landscape in the pharmaceutical industry.
FAQs
-
What diseases does the patent cover?
The patent covers methods for treating acromegaly, idiopathic intracranial hypertension, and cluster headache syndrome.
-
What are the key dosage forms mentioned in the patent?
The patent involves the use of capsules and suspensions as dosage forms.
-
How does the patent affect the pharmaceutical industry?
The patent incentivizes innovation and affects the competitive landscape by preventing other companies from using the same method without permission.
-
What metrics are used to measure patent scope?
Metrics such as independent claim length and count are used to measure patent scope and quality.
-
How is the value of a patent like US 10,238,709 determined?
The value can be determined using the income approach, market approach, or cost approach, considering factors like future benefits and market demand.
Sources
- US10238709B2 - Method of treating diseases - Google Patents
- ANDA Litigation Settlements | Hatch-Waxman | Robins Kaplan LLP
- Patent Claims and Patent Scope - Search eLibrary :: SSRN
- The value of a patent - Perpetual Motion Patents
